Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 4,272
Out of 4,944 analysts
5
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.08 | -11.89% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.31 | +148.09% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $25.68 | -14.33% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $32.09 | +99.44% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.08
Upside: -11.89%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.31
Upside: +148.09%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $25.68
Upside: -14.33%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $32.09
Upside: +99.44%